Accordingly, this article aims to synthesize and analyze the immunohistochemical implications of breast cancer brain metastases, focusing on confirming breast origin with specific markers, molecular characterization of hormone receptors and HER2/neu in metastases, evaluation of discordance with primary tumors, and the impact of these findings on therapeutic and prognostic decision-making. Here, ERBB2 is linked to breast carcinoma.